CompletedPhase 4ketamine

Ketamine Versus Etomidate for Rapid Sequence Intubation

Sponsored by Hennepin Healthcare Research Institute

NCT ID
NCT01823328
Target Enrollment
143 participants
Start Date
2013-09
Est. Completion
2015-10

About This Study

The purpose of this study is to compare the effectiveness and safety of ketamine and etomidate during rapid sequence intubation (RSI).

Conditions Studied

Airway ControlAnesthesiaIntubationComplication

Interventions

  • Ketamine
  • Etomidate

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* 18 years of age
* Undergoing rapid sequence intubation (RSI) in the Emergency Department

Exclusion Criteria:

* Known contraindication to ketamine or etomidate
* Patient has a condition in which an increase in heart rate or blood pressure would be hazardous, as judged by the treating physician
* Patient is known or suspected of having increased intracranial pressure, based on the history and physical examination performed by the treating physician.
* Females of child-bearing age, defined as 18-50 years, who do not have a documented pregnancy test in this institution confirming that they are not pregnant or who do not have a confirmed surgical procedure preventing pregnancy, i.e., tubal ligation, hysterectomy. The timing of the pregnancy test at which the investigative team will consider a subject to be non-pregnant is a documented negative test during current hospitalization or upon direct transfer from outside institution during current illness.
* Patient declines participation in the trial by wearing a bracelet marked "KvE declined"
* Prisoner

Study Locations (1)

Hennepin County Medical Center
Minneapolis, Minnesota, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source